相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thermal Comfort Intervention for Hot-flash Related Insomnia Symptoms in Perimenopausal and Postmenopausal-aged Women: An Exploratory Study
Jordana Composto et al.
BEHAVIORAL SLEEP MEDICINE (2021)
Melatonin and Depression: A Translational Perspective From Animal Models to Clinical Studies
Andre C. Tonon et al.
FRONTIERS IN PSYCHIATRY (2021)
Melatonin up-regulates bone marrow mesenchymal stem cells osteogenic action but suppresses their mediated osteoclastogenesis via MT2-inactivated NF-κB pathway
Yi Zhou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The preclinical discovery and development of agomelatine for the treatment of depression
George Konstantakopoulos et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Insomnia and menopause: a narrative review on mechanisms and treatments
P. Proserpio et al.
CLIMACTERIC (2020)
Do peripheral melatonin agonists improve bone fracture healing? The effects of agomelatine and ramelteon on experimental bone fracture
Duygu Kose et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Agomelatine for depression: expanding the horizons?
Trevor R. Norman et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment
Hong Fang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
Richard Eastell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Insomnia and depressive symptoms during the menopausal transition: theoretical and therapeutic implications of a self-reinforcing feedback loop
Danila Caruso et al.
MATURITAS (2019)
An integrated approach to diagnosing and managing sleep disorders in menopausal women
Marta Caretto et al.
MATURITAS (2019)
Melatonin: Another avenue for treating osteoporosis?
Tian Li et al.
JOURNAL OF PINEAL RESEARCH (2019)
Treating insomnia improves depression, maladaptive thinking, and hyperarousal in postmenopausal women: comparing cognitive-behavioral therapy for insomnia (CBTI), sleep restriction therapy, and sleep hygiene education
David A. Kalmbach et al.
SLEEP MEDICINE (2019)
Postmenopausal Osteoporosis: A Clinical Review
Nelson B. Watts
JOURNAL OF WOMENS HEALTH (2018)
Sleep problems during the menopausal transition: prevalence, impact, and management challenges
Fiona C. Baker et al.
NATURE AND SCIENCE OF SLEEP (2018)
Emerging evidence on the link between depressive symptoms and bone loss in postmenopausal women
Elizabeth Mollard et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2018)
Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway
Kunal Sharan et al.
JOURNAL OF PINEAL RESEARCH (2017)
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits
Anke R. Hammerschlag et al.
NATURE GENETICS (2017)
Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis
Dahima Cintron et al.
ENDOCRINE (2017)
Patterns of depressive disorders across 13 years and their determinants among midlife women: SWAN mental health study
Joyce T. Bromberger et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
DSM-5 Insomnia and Short Sleep: Comorbidity Landscape and Racial Disparities
David A. Kalmbach et al.
SLEEP (2016)
DSM-5 Insomnia and Short Sleep: Comorbidity Landscape and Racial Disparities
David A. Kalmbach et al.
SLEEP (2016)
Treatment of chronic insomnia disorder in menopause: evaluation of literature
Hrayr Attarian et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2015)
Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic Approaches
Joshua Z. Tal et al.
CURRENT PSYCHIATRY REVIEWS (2015)
The therapeutic or prophylactic effect of exogenous melatonin against depression and depressive symptoms: A systematic review and meta-analysis
M. V. Hansen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
EPA-1061 – Agomelatine in the treatment of perimenopausal depression - a pilot study
S. Krüger et al.
EUROPEAN PSYCHIATRY (2014)
Menopause and depression: Is there a link?
Josephine Vivian-Taylor et al.
MATURITAS (2014)
The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
Domenico De Berardis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder: A Placebo-Controlled Study
Reinhard Heun et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Synergistic mechanisms involved in the antidepressant effects of agomelatine
Daniela Tardito et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal
Surendra P. Singh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Melatonin and its analogs in insomnia and depression
Daniel P. Cardinali et al.
JOURNAL OF PINEAL RESEARCH (2012)
An exploratory study of combination buspirone and melatonin SR in Major Depressive Disorder (MDD): A possible role for neurogenesis in drug discovery
Maurizio Fava et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response
Alan G. Wade et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients
Maria-Antonia Quera-Salva et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis
Suhair Jabbar et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Melatonin agonists in primary insomnia and depression-associated insomnia: Are they superior to sedative-hypnotics?
Venkatramanujan Srinivasan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Agomelatine in the Treatment of Major Depressive Disorder Potential for Clinical Effectiveness
Sidney H. Kennedy et al.
CNS DRUGS (2010)
Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients
Maria-Antonia Quera-Salva et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood
Marc Antony Serfaty et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
S. J. Wilson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Cognitive-Emotional Hyperarousal as a Premorbid Characteristic of Individuals Vulnerable to Insomnia
Julio Fernandez-Mendoza et al.
PSYCHOSOMATIC MEDICINE (2010)
Agomelatine Efficacy at Each Phase of Antidepressant Treatment
Sidney H. Kennedy
CNS DRUGS (2009)
Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine
Seithikurippu R. Pandi-Perumal et al.
PROGRESS IN NEUROBIOLOGY (2009)
Agomelatine: A novel mechanism of antidepressant action involving the melatonergic and the serotonergic system
Luis San et al.
EUROPEAN PSYCHIATRY (2008)
Biology of RANK, RANKL, and osteoprotegerin
Brendan F. Boyce et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Severe hot flashes are associated with chronic insomnia
MM Ohayon
ARCHIVES OF INTERNAL MEDICINE (2006)
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview
JL Carrasco et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Place of chronic insomnia in the course of depressive and anxiety disorders
MM Ohayon et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2003)
分享论文
